FLUMIST AstraZeneca Pty Ltd
Product name
FLUMIST
Sponsor
Accepted date
Dec-2024
Active ingredients
Influenza virus
Proposed indication
FLUMIST is indicated for the prevention of influenza in individuals 2 years to 49 years of age.
Application type
C (new indication)
Publication date
Dec-2024